Tag Archives | S Doumbia

Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals

Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, Williams L, Mazibuko G.Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407.

Read the full article

Read full story · Comments are closed

Defeating malaria through pharmaceutical systems strengthening

SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.

Read full story · Comments are closed

HIV and AIDS Commodity Management Tool for West Africa (OSPSIDA): Technical Guide

The West Africa Regional HIV Pharmaceutical Management Information Dashboard is developed and implemented for fifteen focus West African countries for better management of HIV and AIDS commodities. The goal of the Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard will assist focus countries and subregional organizations in improving forecasting, supply planning, and procurement to support the continuous availability of ARVs, RTKs, and other HIV- and AIDS-related commodities.

Read full story · Comments are closed

HIV and AIDS Commodity Management Tool for West Africa (OSPSIDA): User Guide

The goal of the OSPSIDA Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard offers regional partners a platform through which they may easily share information on funding flows and stock-out risks. The data available on this platform will be used to inform decision making and assist in identifying solutions to mitigate risks in the short-, medium-, and long-term. This User Guide assists users to make entries into the OSPSIDA Dashboard smoothly. The user guide has step-by-step guidance on how to access the dashboard, enter information, and generate reports.

Read full story · Comments are closed

Transition of the HIV and AIDS Commodity Management Tool (OSPSIDA) to the West African Health Organization and Cameroon: Lessons Learned and Recommendations

USAID’s West African office asked SIAPS to provide support to six countries in the West and Central African region—Burkina Faso, Benin, Cameroon, Guinea, Niger, and Togo—to establish a web-based regional dashboard (OSPSIDA.org) that will create an early warning system (EWS) to monitor HIV and AIDS commodities and to detect and minimize the risk of stock-out in the focus countries.

In pursuit of this objective, and to ensure local ownership and long-term sustainability, the West African Health Organization (WAHO) has been involved since the project’s inception and has provided useful input during the design phase and official launch in Accra in April 2014. However, for the long-term sustainability of the dashboard and in an effort to support WAHO’s strategy of setting up security stock for West African countries, it is necessary to transfer the dashboard to WAHO’s Essential Medicines and Vaccines Program  as its final home.

Read full story · Comments are closed

Étude de faisabilité de l’élargissement de l’accès aux TDR et CTA dans les pharmacies du secteur privé au Mali : Rapport de recherche

La présente étude vise à examiner la faisabilité d’une introduction des tests de diagnostic rapide (TDR) et combinaisons thérapeutiques à base d’artémisinine (CTA) subventionnés pour la prise en charge du paludisme dans les pharmacies du secteur privé au Mali, et déterminer quels éléments doivent être pris en compte afin de garantir que cette introduction s’effectue de manière réaliste, acceptable, efficace et pérenne.

Read full story · Comments are closed

Quantification report on family planning commodities for the period January 2014 to December 2018

The promotion of family planning (FP) and access to desired contraceptive methods for women and couples are essential steps to ensuring the well-being and empowerment of women, while also supporting the health and development of communities. It provides opportunities to prevent high-risk pregnancies, which contribute to the high maternal mortality and morbidity rate or to disability. Family planning helps reduce infant mortality by preventing closely-spaced or poorly timed pregnancies. Family planning also reduces the risk of unintended pregnancies among women living with HIV, which reduces the number of babies and orphans who are infected. Male and female condoms offer dual protection against unintended pregnancies and sexually transmitted infections (STIs), including HIV. In addition, FP has long-term benefits, including empowering individuals, improving education and increasing productivity.

A quantification exercise for FP commodities was conducted with technical assistance from UNFPA and USAID | SIAPS and participation from all key stakeholders with the goal of generating the forecasted requirements and a supply plan for the period 2014 to 2018. The results from this quantification exercise will be used in planning to mobilize and obtain financial resources for the quantification period. For purposes of comparison and validation, two forecasting methods were used for this exercise, the demographic/morbidity method and the consumption method. Forecasting of requirements was estimated for the entire country (public sector and social marketing) for each method. The supply plan was developed for the two sectors. After sharing the quantification results with the national committee for the coordination and monitoring of the management of essential medicines, the quantification results from the morbidity method were validated on 11 June 2014.

Read full story · Comments are closed

Costing the Supply Chain for Delivery of ACTs and RDTs in the Public Sector in Benin and Kenya

Shretta R, Johnson B, Smith L, Doumbia S, de Savigny D, Anupindi R, Yadav P. Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya. Malaria Journal. 2015; 14:57.

Read the full article

Read full story · Comments are closed

Estimating the In-Country Distribution Costs of Malaria Commodities in Benin and Kenya

This report estimates the cost of the Kenyan and Beninese distribution networks for artemisininbased combination therapies (ACTs) and rapid diagnostic tests (RDTs) in the public sector. Based on this work, we created an extrapolative model to allow donors and country budget planners to quickly and effectively estimate distribution costs for country roadmaps. This model is presented in a separate document.

This report achieved four objectives: (1) allow accurate costing for the delivery of malaria commodities to the end user, (2) allow accurate planning and budgeting, (3) provide realistic estimates of distribution costs for inclusion in roadmaps and proposals, and (4) inform policy discussion by improving the accuracy of costing for ACT and RDT supply chains.

Read full story · Comments are closed

Haiti Pharmaceutical Sector Technical Assistance Priorities

Download

Access to medicines remains a major issue for the Haitian population. National-level statistics show that less than half the population has acceptable access to medicines. In addition, for those who have access, there is no guarantee of the quality of medicines. As part of the strategy to reform the health system, the MSPP has decided to develop a new NMP. This policy is a commitment from the nation to provide quality pharmaceutical services to the Haitian population on the basis of equity and justice.

Read full story · Comments are closed